Urocap 0.4 mg (Capsule (Modified Release))
Unit Price: ৳ 10.00 (3 x 10: ৳ 300.00)
Strip Price: ৳ 100.00
Medicine Details
| Category | Details |
|---|---|
| Generic | Tamsulosin hydrochloride |
| Company | Ibn sina pharmaceuticals ltd |
Indications
- Treatment of functional symptoms of Benign Prostatic Hyperplasia (BPH)
Pharmacology
- Selective alpha1 adrenoceptor blocking agent
- Relaxes smooth muscle in the bladder neck and prostate
- Improves urine flow rate
- Reduces symptoms of BPH
- Absorption of 90% under fasting conditions
- Extensively metabolized by liver enzymes
Dosage & Administration
- Tamsulosin Hydrochloride 0.4 mg daily
- May be increased to 0.8 mg once daily after 2 to 4 weeks
- Swallow whole with a glass of water
- Should not be crunched or chewed
Interaction
- Concurrent administration with other alfa1-adrenoceptor antagonists can lead to hypotensive effects
- No interactions with atenolol, enalapril or nifedipine
- Cimetidine may increase plasma levels, frusemide may decrease levels
- No interactions at hepatic metabolism level with amitriptyline, salbutamol, etc.
- Diclofenac and warfarin may increase elimination rate
Contraindications
- Hypersensitivity to Tamsulosin hydrochloride
- History of orthostatic hypotension
- Severe hepatic insufficiency
- Potential reduction in blood pressure leading to syncope
- Caution in situations where injury could result
- Examination to exclude other conditions before therapy initiation
Side Effects
- Dizziness
- Abnormal ejaculation
- Headache
- Asthenia
- Postural hypotension
- Palpitations
Pregnancy & Lactation
- Not recommended for use
Precautions & Warnings
- Rare transient postural symptoms may occur
- Not advised in patients with micturition syncope
- No data available on effects on ability to drive or operate machines
- Patients should be aware of the potential for dizziness
Overdose Effects
- Acute hypotension likely after overdosage
- Cardiovascular support should be given
- Renal function monitoring and general supportive measures suggested
- Measures such as emesis, gastric lavage and activated charcoal may be taken
Therapeutic Class
- BPH/Urinary retention/Urinary incontinence
Storage Conditions
- Store in a cool and dry place below 30°C, protected from light
Related Brands
- Flonor 0.4 mg (Capsule (Modified Release)) - novo-healthcare-and-pharma-ltd
- Maxflo-U 0.4 mg (Capsule (Modified Release)) - rangs-pharmaceuticals-ltd
- Tamfast 0.4 mg (Capsule (Modified Release)) - radiant-pharmaceuticals-ltd
- Prostacin 0.4 mg (Capsule (Modified Release)) - incepta-pharmaceuticals-ltd
- Prostam 0.4 mg (Capsule (Modified Release)) - drug-international-ltd